{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:30:39Z","timestamp":1787574639992,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Psoriasis is skin inflammation caused by an immune system dysfunction, involving a complex interaction between immune cells and keratinocytes. The aim of this study was to develop nanoemulsion (NE) based hydrogel containing ferulic acid, a poorly water-soluble compound and evaluate its effect on imiquimod induced psoriasis like skin inflammation. Ferulic acid nanoemulsion (FA-NE) was prepared by ultra-sonication method. Castor oil, Tween-80 and propylene glycol were selected for NE preparation as oil phase surfactant and cosurfactant respectively based on solubility. The NE particle size (29.8\u2009\u00b1\u20090.49\u00a0nm) was within colloidal range, polydispersity index (0.21\u2009\u00b1\u20090.02) showed homogenous NE, zeta potential (28.5\u2009\u00b1\u20090.57 mV) indicated stable NE. Entrapment efficiency (96.26\u2009\u00b1\u20090.33%) and pH (6.8\u2009\u00b1\u20090.15) was also in suitable range. The rheological study results of FA-NE hydrogel indicated pseudoplastic behavior. The pH and spreadibility were 6.2\u2009\u00b1\u20090.15 and 8.2\u2009\u00b1\u20090.89 respectively, suitable for topical application. The optimized FA-NE hydrogel was tested on male Wistar rats (100\u2013150\u00a0g) divided into five groups (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20095). Psoriasis like disease was induced by applying 5% imiquimod (IMQ) cream for 7 days on the shaved dorsal skin of four groups (except normal group) and psoriasis area severity index (PASI) scoring were calculated. The application of optimized FA-NE hydrogel dramatically reduced TNF-\u03b1, IL-6, IL-17\u00a0A, IL-23, superoxide dismutase, glutathione peroxidase, malondialdehyde and catalase biomarkers when compared to the disease group. These results were consistent with the in-silico docking studies with highest docking score observed with TNF-\u03b1. The treatment group\u2019s spleen index reduced significantly. Histopathological findings showed increased capillaries, skin thinning, small dermal projections, and inflammatory cells around blood vessels with 5% IMQ cream application and FA-NE hydrogel greatly reduced these psoriatic changes. Immunohistochemical Ki-67 analysis demonstrated that disease control rats expressed more protein than normal, treatment, and standard animals. The FA-NE hydrogel effectively reduced inflammation and oxidative stress in a rat model of psoriasis, suggesting its potential as a topical treatment.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-57435-z","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:06:30Z","timestamp":1781100390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preparation, characterization and in-vivo evaluation of nanoemulsion based hydrogel of ferulic acid in imiquimod-induced psoriasis in rats"],"prefix":"10.1038","volume":"16","author":[{"given":"Nosheen","family":"Naseer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3526-4132","authenticated-orcid":false,"given":"Sairah Hafeez","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misbah","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiqa","family":"Ishtiaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Farhan","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ismail","family":"Mastoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"57435_CR1","doi-asserted-by":"publisher","first-page":"102328","DOI":"10.1016\/j.jddst.2021.102328","volume":"62","author":"M Bhat","year":"2021","unstructured":"Bhat, M., Pukale, S., Singh, S., Mittal, A. & Chitkara, D. Nano-enabled topical delivery of anti-psoriatic small molecules. J. Drug Deliv. Sci. Technol. 62, 102328. https:\/\/doi.org\/10.1016\/j.jddst.2021.102328 (2021).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"57435_CR2","doi-asserted-by":"publisher","unstructured":"Dhabale, A. & Nagpure, S. Types of psoriasis and their effects on the immune system. Cureus 14 https:\/\/doi.org\/10.7759\/cureus.29536 (2022).","DOI":"10.7759\/cureus.29536"},{"key":"57435_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/cei.13363","volume":"198","author":"C Liu","year":"2019","unstructured":"Liu, C. et al. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model. Clin. Experimental Immunol. 198, 403\u2013415. https:\/\/doi.org\/10.1111\/cei.13363 (2019).","journal-title":"Clin. Experimental Immunol."},{"key":"57435_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.fct.2019.04.060","volume":"129","author":"HY Lo","year":"2019","unstructured":"Lo, H. Y. et al. Ferulic acid altered IL-17A\/IL-17RA interaction and protected against imiquimod-induced psoriasis-like skin injury in mice. Food Chem. Toxicol. 129, 365\u2013375. https:\/\/doi.org\/10.1016\/j.fct.2019.04.060 (2019).","journal-title":"Food Chem. Toxicol."},{"key":"57435_CR5","doi-asserted-by":"publisher","first-page":"113664","DOI":"10.1016\/j.jconrel.2025.113664","volume":"382","author":"J Yang","year":"2025","unstructured":"Yang, J., Zhu, J., Lu, S., Qin, H. & Zhou, W. Transdermal psoriasis treatment inspired by tumor microenvironment-mediated immunomodulation and advanced by exosomal engineering. J. Controlled Release. 382, 113664. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113664 (2025).","journal-title":"J. Controlled Release"},{"key":"57435_CR6","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1002\/ptr.6973","volume":"35","author":"N Dabholkar","year":"2021","unstructured":"Dabholkar, N., Rapalli, V. K. & Singhvi, G. Potential herbal constituents for psoriasis treatment as protective and effective therapy. Phytother. Res. 35, 2429\u20132444 (2021).","journal-title":"Phytother. Res."},{"key":"57435_CR7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jddst.2019.06.008","volume":"52","author":"R Kaur","year":"2019","unstructured":"Kaur, R. & Ajitha, M. Formulation of transdermal nanoemulsion gel drug delivery system of lovastatin and its in vivo characterization in glucocorticoid induced osteoporosis rat model. J. Drug Delivery Sci. 52, 968\u2013978 (2019).","journal-title":"J. Drug Delivery Sci."},{"key":"57435_CR8","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.2174\/0929867327666200831125656","volume":"28","author":"FG Baveloni","year":"2021","unstructured":"Baveloni, F. G. et al. Nanotechnology-based drug delivery systems as potential for skin application: a review. Curr. Med. Chem. 28, 3216\u20133248. https:\/\/doi.org\/10.2174\/0929867327666200831125656 (2021).","journal-title":"Curr. Med. Chem."},{"key":"57435_CR9","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.3390\/ijms22115514","volume":"22","author":"F Truzzi","year":"2021","unstructured":"Truzzi, F., Tibaldi, C., Zhang, Y., Dinelli, G. & D\u2032 Amen, E. An overview on dietary polyphenols and their biopharmaceutical classification system (BCS). Int. J. Mol. Sci. 22, 5514. https:\/\/doi.org\/10.3390\/ijms22115514 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"57435_CR10","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.2174\/1389557521666210120111702","volume":"21","author":"R Babbar","year":"2021","unstructured":"Babbar, R., Dhiman, S., Grover, R., Kaur, A. & Arora, S. A comprehensive review on therapeutic applications of ferulic acid and its novel analogues: A brief literature. Mini Rev. Med. Chem. 21, 1578\u20131593 (2021).","journal-title":"Mini Rev. Med. Chem."},{"key":"57435_CR11","doi-asserted-by":"crossref","unstructured":"Purushothaman, J. R. & Rizwanullah, M. & Purushothaman Sr, R. Ferulic acid: a comprehensive review. Cureus 16 (2024).","DOI":"10.7759\/cureus.68063"},{"key":"57435_CR12","doi-asserted-by":"crossref","unstructured":"Shukla, D. et al. Enhanced antichemobrain activity of amino acid assisted ferulic acid solid dispersion in adult zebrafish (Danio rerio). 14, 3422\u20133437 (2024).","DOI":"10.1007\/s13346-024-01546-5"},{"key":"57435_CR13","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2174\/1381612826666201020163331","volume":"27","author":"GR Cavalcanti","year":"2021","unstructured":"Cavalcanti, G. R., Duarte, F. I. & Converti, A. Lima, \u00c1. A. Ferulic acid activity in topical formulations: technological and scientific prospecting. Curr. Pharm. Design. 27, 2289\u20132298. https:\/\/doi.org\/10.2174\/1381612826666201020163331 (2021). de.","journal-title":"Curr. Pharm. Design"},{"key":"57435_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.lfs.2015.10.001","volume":"141","author":"RK Harwansh","year":"2015","unstructured":"Harwansh, R. K., Mukherjee, P. K., Bahadur, S. & Biswas, R. Enhanced permeability of ferulic acid loaded nanoemulsion based gel through skin against UVA mediated oxidative stress. Life Sci. 141, 202\u2013211. https:\/\/doi.org\/10.1016\/j.lfs.2015.10.001 (2015).","journal-title":"Life Sci."},{"key":"57435_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/17425247.2023.2154075","volume":"20","author":"X Wang","year":"2023","unstructured":"Wang, X., Anton, H., Vandamme, T. & Anton, N. Updated insight into the characterization of nano-emulsions. Expert Opin. Drug Deliv. 20, 93\u2013114. https:\/\/doi.org\/10.1080\/17425247.2023.2154075 (2023).","journal-title":"Expert Opin. Drug Deliv."},{"key":"57435_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1080\/10717544.2022.2039805","volume":"29","author":"U Gul","year":"2022","unstructured":"Gul, U. et al. Olive oil and clove oil-based nanoemulsion for topical delivery of terbinafine hydrochloride: in vitro and ex vivo evaluation. Drug Deliv. 29, 600\u2013612 (2022).","journal-title":"Drug Deliv."},{"key":"57435_CR17","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.3390\/foods12173183","volume":"12","author":"S Zhao","year":"2023","unstructured":"Zhao, S. et al. Characterization of nanoemulsions stabilized with different emulsifiers and their encapsulation efficiency for oregano essential oil: Tween 80, soybean protein isolate, tea saponin, and soy lecithin. Foods 12, 3183 (2023).","journal-title":"Foods"},{"key":"57435_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.bjp.2016.11.005","volume":"27","author":"AE Oliveira","year":"2017","unstructured":"Oliveira, A. E. et al. Utilization of dynamic light scattering to evaluate Pterodon emarginatus oleoresin-based nanoemulsion formation by non-heating and solvent-free method. Revista Brasileira de Farmacognosia. 27, 401\u2013406. https:\/\/doi.org\/10.1016\/j.bjp.2016.11.005 (2017).","journal-title":"Revista Brasileira de Farmacognosia"},{"key":"57435_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.lfs.2015.10.001","volume":"141","author":"RK Harwansh","year":"2015","unstructured":"Harwansh, R. K., Mukherjee, P. K., Bahadur, S. & Biswas, R. Enhanced permeability of ferulic acid loaded nanoemulsion based gel through skin against UVA mediated oxidative stress. Life Sci. 141, 202\u2013211 (2015).","journal-title":"Life Sci."},{"key":"57435_CR20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/pharmaceutics18030348","volume":"18","author":"A Mushtaq","year":"2026","unstructured":"Mushtaq, A. et al. Development and Characterization of Heparin\u2013Pullulan Liposomal Nano-Gel for Enhanced Silymarin Delivery in Dementia Therapy: In Vivo Evaluation in Albino Mice. Pharmaceutics 18, 348. https:\/\/doi.org\/10.3390\/pharmaceutics18030348 (2026).","journal-title":"Pharmaceutics"},{"key":"57435_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/life12071011","volume":"12","author":"HS Elsewedy","year":"2022","unstructured":"Elsewedy, H. S., Shehata, T. M. & Soliman, W. E. Tea tree oil nanoemulsion-based hydrogel vehicle for enhancing topical delivery of neomycin. Life 12, 1011 (2022).","journal-title":"Life"},{"key":"57435_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/21691401.2014.887018","volume":"43","author":"M Laxmi","year":"2015","unstructured":"Laxmi, M., Bhardwaj, A., Mehta, S. & Mehta, A. Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether. Artif. cells Nanomed. Biotechnol. 43, 334\u2013344. https:\/\/doi.org\/10.3109\/21691401.2014.887018 (2015).","journal-title":"Artif. cells Nanomed. Biotechnol."},{"key":"57435_CR23","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1208\/s12249-016-0674-0","volume":"18","author":"M Sultana","year":"2017","unstructured":"Sultana, M. et al. Effect of Rheology and Poloxamers Properties on Release of Drugs from Silicon Dioxide Gel-Filled Hard Gelatin Capsules\u2014A Further Enhancement of Viability of Liquid Semisolid Matrix Technology. AAPS PharmSciTech. 18, 1998\u20132010. https:\/\/doi.org\/10.1208\/s12249-016-0674-0 (2017).","journal-title":"AAPS PharmSciTech"},{"key":"57435_CR24","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/gels8090578","volume":"8","author":"R Sevin\u00e7-\u00d6zakar","year":"2022","unstructured":"Sevin\u00e7-\u00d6zakar, R., Seyret, E., \u00d6zakar, E. & Ad\u0131g\u00fczel, M. C. Nanoemulsion-based hydrogels and organogels containing propolis and dexpanthenol: Preparation, characterization, and comparative evaluation of stability, antimicrobial, and cytotoxic properties. Gels 8, 578 (2022).","journal-title":"Gels"},{"key":"57435_CR25","doi-asserted-by":"publisher","first-page":"12288","DOI":"10.1038\/s41598-020-68732-6","volume":"10","author":"S Das","year":"2020","unstructured":"Das, S. & B Wong, A. Stabilization of ferulic acid in topical gel formulation via nanoencapsulation and pH optimization. Sci. Rep. 10, 12288. https:\/\/doi.org\/10.1038\/s41598-020-68732-6 (2020).","journal-title":"Sci. Rep."},{"key":"57435_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijpharm.2015.05.030","volume":"490","author":"AO Abioye","year":"2015","unstructured":"Abioye, A. O., Issah, S. & Kola-Mustapha, A. T. Ex vivo skin permeation and retention studies on chitosan\u2013ibuprofen\u2013gellan ternary nanogel prepared by in situ ionic gelation technique\u2014a tool for controlled transdermal delivery of ibuprofen. Int. J. Pharm. 490, 112\u2013130. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.05.030 (2015).","journal-title":"Int. J. Pharm."},{"key":"57435_CR27","doi-asserted-by":"publisher","unstructured":"Arora, R., Aggarwal, G., Harikumar, S. & Kaur, K. Nanoemulsion based hydrogel for enhanced transdermal delivery of ketoprofen. Advances in Pharmaceutics 468456, (2014). https:\/\/doi.org\/10.1155\/2014\/468456 (2014).","DOI":"10.1155\/2014\/468456"},{"key":"57435_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/pharmaceutics16030366","volume":"16","author":"G Kasparaviciene","year":"2024","unstructured":"Kasparaviciene, G. et al. Development and Evaluation of Two-Phase Gel Formulations for Enhanced Delivery of Active Ingredients: Sodium Diclofenac and Camphor. Pharmaceutics 16, 366. https:\/\/doi.org\/10.3390\/pharmaceutics16030366 (2024).","journal-title":"Pharmaceutics"},{"key":"57435_CR29","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.4314\/tjpr.v18i11","volume":"18","author":"SQ Wang","year":"2019","unstructured":"Wang, S. Q. et al. Design of dual inhibitors of human TNF-\u03b1 and IL-6 with potentials for the treatment of rheumatoid arthritis. Trop. J. Pharm. Res. 18, 2305\u20132312. https:\/\/doi.org\/10.4314\/tjpr.v18i11 (2019).","journal-title":"Trop. J. Pharm. Res."},{"key":"57435_CR30","doi-asserted-by":"publisher","first-page":"105200","DOI":"10.1016\/j.arabjc.2023.105200","volume":"16","author":"RM Aldossari","year":"2023","unstructured":"Aldossari, R. M. et al. Insights on in-silico approaches for identifying potential bioactive inhibitors for TNF-\u03b1 and IL-6 proteins associated with rheumatoid arthritis. Arab. J. Chem. 16, 105200. https:\/\/doi.org\/10.1016\/j.arabjc.2023.105200 (2023).","journal-title":"Arab. J. Chem."},{"key":"57435_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.56808\/3027-7922.2448","volume":"44","author":"JR Patel","year":"2020","unstructured":"Patel, J. R., Joshi, H. V., Shah, U. A. & Patel, J. K. In silico screening of natural compounds to identify lead as interleukin 17A receptor blockers as antihypertensive agents. Thai J. Pharm. Sci. 44, 168\u2013173. https:\/\/doi.org\/10.56808\/3027-7922.2448 (2020).","journal-title":"Thai J. Pharm. Sci."},{"key":"57435_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s40203-023-00188-8","volume":"12","author":"A Gupta","year":"2024","unstructured":"Gupta, A. et al. Cytokines inhibitory mechanism of Prunus domestica L.(Plum) peptides as potential immunomodulators against systemic lupus erythematosus: an in-silico screening. Silico Pharmacol. 12, 12. https:\/\/doi.org\/10.1007\/s40203-023-00188-8 (2024).","journal-title":"Silico Pharmacol."},{"key":"57435_CR33","doi-asserted-by":"publisher","unstructured":"Hassan, I., Zaman, A., Zafar, E. & Khan, M. Molecular Docking-Aided Identification of Natural Bioactive Molecules as Potential Cancer Cell Proliferation Inhibitors: Molecular Docking as Cancer Cell Inhibitors. Futuristic Biotechnol. 25\u201330. https:\/\/doi.org\/10.54393\/fbt.v4i02.105 (2024).","DOI":"10.54393\/fbt.v4i02.105"},{"key":"57435_CR34","doi-asserted-by":"publisher","first-page":"e0303060","DOI":"10.1371\/journal.pone.0303060","volume":"19","author":"A Iqbal","year":"2024","unstructured":"Iqbal, A. et al. Modulatory effects of rutin and vitamin A on hyperglycemia induced glycation, oxidative stress and inflammation in high-fat-fructose diet animal model. Plos one. 19, e0303060. https:\/\/doi.org\/10.1371\/journal.pone.0303060 (2024).","journal-title":"Plos one"},{"key":"57435_CR35","doi-asserted-by":"publisher","first-page":"e202304385","DOI":"10.1002\/slct.202304385","volume":"9","author":"S Muntaha","year":"2024","unstructured":"Muntaha, S. et al. Biochemical, molecular characterization, antioxidant, and cytotoxicity of Dicliptera bupleuroides with potential drug discovery: in vitro and in silico analysis. ChemistrySelect 9, e202304385. https:\/\/doi.org\/10.1002\/slct.202304385 (2024).","journal-title":"ChemistrySelect"},{"key":"57435_CR36","doi-asserted-by":"publisher","first-page":"1934578X2412308","DOI":"10.1177\/1934578X241230822","volume":"19","author":"A Labhar","year":"2024","unstructured":"Labhar, A. et al. Seasonal Variations in the Essential Oil Composition and Biological Activities of Wild Lavandula dentata L. Nat. Prod. Commun. 19, 1934578X241230822. https:\/\/doi.org\/10.1177\/1934578X241230822 (2024).","journal-title":"Nat. Prod. Commun."},{"key":"57435_CR37","doi-asserted-by":"publisher","first-page":"7084","DOI":"10.1080\/07391102.2022.2119602","volume":"41","author":"M Azeem","year":"2023","unstructured":"Azeem, M. et al. Design, synthesis, spectroscopic characterization, in-vitro antibacterial evaluation and in-silico analysis of polycaprolactone containing chitosan-quercetin microspheres. J. Biomol. Struct. Dynamics. 41, 7084\u20137103. https:\/\/doi.org\/10.1080\/07391102.2022.2119602 (2023).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"57435_CR38","doi-asserted-by":"publisher","first-page":"903160","DOI":"10.3389\/fphar.2022.903160","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang, S. et al. Efficacy and safety of curcumin in psoriasis: preclinical and clinical evidence and possible mechanisms. Front. Pharmacol. 13, 903160. https:\/\/doi.org\/10.3389\/fphar.2022.903160 (2022).","journal-title":"Front. Pharmacol."},{"key":"57435_CR39","doi-asserted-by":"crossref","unstructured":"Yang, Y. et al. An emerging role of proanthocyanidins on psoriasis: evidence from a psoriasis-like mouse model. Oxidative medicine cellular longevity 5800586 (2022). (2022).","DOI":"10.1155\/2022\/5800586"},{"key":"57435_CR40","doi-asserted-by":"publisher","unstructured":"Yang, Y. et al. An emerging role of proanthocyanidins on psoriasis: evidence from a psoriasis-like mouse model. Oxidative Med. Cell. Longev. 2022 (5800586). https:\/\/doi.org\/10.1155\/2022\/5800586 (2022).","DOI":"10.1155\/2022\/5800586"},{"key":"57435_CR41","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/pharmaceutics12090789","volume":"12","author":"M Jabeen","year":"2020","unstructured":"Jabeen, M. et al. Advanced characterization of imiquimod-induced psoriasis-like mouse model. Pharmaceutics 12, 789 (2020).","journal-title":"Pharmaceutics"},{"key":"57435_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jconrel.2017.03.385","volume":"254","author":"L Sun","year":"2017","unstructured":"Sun, L. et al. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel. J. Controlled Release. 254, 44\u201354 (2017).","journal-title":"J. Controlled Release"},{"key":"57435_CR43","doi-asserted-by":"crossref","unstructured":"Jabeen, M. et al. Advanced characterization of imiquimod-induced psoriasis-like mouse model. 12, 789 (2020).","DOI":"10.3390\/pharmaceutics12090789"},{"key":"57435_CR44","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1080\/01635581.2020.1860242","volume":"73","author":"M Shahbaz","year":"2021","unstructured":"Shahbaz, M., Kamran, S. H. & Anwar, R. Amelioration of bleomycin and methotrexate-induced pulmonary toxicity by serratiopeptidase and fisetin. Nutr. Cancer. 73, 2774\u20132784. https:\/\/doi.org\/10.1080\/01635581.2020.1860242 (2021).","journal-title":"Nutr. Cancer"},{"key":"57435_CR45","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3892\/mmr.2017.8015","volume":"17","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. Differential expression of cyclin D1, Ki\u201367, pRb, and p53 in psoriatic skin lesions and normal skin. Mol. Med. Rep. 17, 735\u2013742. https:\/\/doi.org\/10.3892\/mmr.2017.8015 (2018).","journal-title":"Mol. Med. Rep."},{"key":"57435_CR46","unstructured":"Rowe, R. C. Handbook of pharmaceutical excipients (Pharmaceutical, 2020)."},{"key":"57435_CR47","doi-asserted-by":"publisher","unstructured":"Fiume, M. M. et al. Safety assessment of propylene glycol, tripropylene glycol, and PPGs as used in cosmetics. Int. J. Toxicol. 31 https:\/\/doi.org\/10.1177\/1091581812461381 (2012). 245S-260S, doi.","DOI":"10.1177\/1091581812461381"},{"key":"57435_CR48","doi-asserted-by":"publisher","unstructured":"Tai, Q. D. et al. Glucose-responsive nanozyme hydrogel for glycemic control and catalytic anti-infective therapy in diabetic wound healing. Mater. Today Bio. 102405 https:\/\/doi.org\/10.1016\/j.mtbio.2025.102405 (2025).","DOI":"10.1016\/j.mtbio.2025.102405"},{"key":"57435_CR49","doi-asserted-by":"publisher","unstructured":"Cerqueira, A. F. L. W., de Mello Brand\u00e3o, H., Tavares, G. D. & Rodarte, M. P. Ferulic Acid: A Review of Mechanisms of Action, Absorption, Toxicology, Application on Wound Healing. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 23, 205\u2013214, (2024). https:\/\/doi.org\/10.2174\/0118715230309592240723105514","DOI":"10.2174\/0118715230309592240723105514"},{"key":"57435_CR50","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/separations11070204","volume":"11","author":"K Pyrzynska","year":"2024","unstructured":"Pyrzynska, K. Ferulic acid\u2014a brief review of its extraction, bioavailability and biological activity. Separations 11, 204. https:\/\/doi.org\/10.3390\/separations11070204 (2024).","journal-title":"Separations"},{"key":"57435_CR51","doi-asserted-by":"publisher","first-page":"119921","DOI":"10.1016\/j.lfs.2021.119921","volume":"284","author":"D Li","year":"2021","unstructured":"Li, D. et al. Ferulic acid: A review of its pharmacology, pharmacokinetics and derivatives. Life Sci. 284, 119921. https:\/\/doi.org\/10.1016\/j.lfs.2021.119921 (2021).","journal-title":"Life Sci."},{"key":"57435_CR52","doi-asserted-by":"publisher","first-page":"12889","DOI":"10.3390\/ijms222312889","volume":"22","author":"M Stompor-Gor\u0105cy","year":"2021","unstructured":"Stompor-Gor\u0105cy, M. & Machaczka, M. Recent advances in biological activity, new formulations and prodrugs of ferulic acid. Int. J. Mol. Sci. 22, 12889 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"57435_CR53","doi-asserted-by":"publisher","first-page":"804415","DOI":"10.3389\/fbioe.2021.804415","volume":"9","author":"N Li","year":"2022","unstructured":"Li, N. et al. Transdermal delivery of therapeutic compounds with nanotechnological approaches in psoriasis. Front. Bioeng. Biotechnol. 9, 804415. https:\/\/doi.org\/10.3389\/fbioe.2021.804415 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"57435_CR54","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/pharmaceutics15020378","volume":"15","author":"B Alhasso","year":"2023","unstructured":"Alhasso, B., Ghori, M. U. & Conway, B. R. Development of Nanoemulsions for Topical Application of Mupirocin. Pharmaceutics 15, 378. https:\/\/doi.org\/10.3390\/pharmaceutics15020378 (2023).","journal-title":"Pharmaceutics"},{"key":"57435_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1208\/s12249-024-02997-2","volume":"26","author":"J Musakhanian","year":"2025","unstructured":"Musakhanian, J. & Osborne, D. W. Understanding microemulsions and nanoemulsions in (trans) dermal delivery. Aaps Pharmscitech. 26, 31. https:\/\/doi.org\/10.1208\/s12249-024-02997-2 (2025).","journal-title":"Aaps Pharmscitech"},{"key":"57435_CR56","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/gels9100794","volume":"9","author":"A Sah","year":"2023","unstructured":"Sah, A. et al. Design and Development of a Topical Nanogel Formulation Comprising of a Unani Medicinal Agent for the Management of Pain. Gels 9, 794. https:\/\/doi.org\/10.3390\/gels9100794 (2023).","journal-title":"Gels"},{"key":"57435_CR57","doi-asserted-by":"publisher","first-page":"107199","DOI":"10.1016\/j.jddst.2025.107199","volume":"111","author":"TM de Almeida","year":"2025","unstructured":"de Almeida, T. M. et al. Ferulic acid-loaded Nanoemulsion Gels: A strategy for enhanced skin delivery and reduced irritation. J. Drug Deliv. Sci. Technol. 111, 107199. https:\/\/doi.org\/10.1016\/j.jddst.2025.107199 (2025).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"57435_CR58","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/pharmaceutics17121532","volume":"17","author":"A To\u0161i\u0107","year":"2025","unstructured":"To\u0161i\u0107, A. et al. Interfacial Molecular Interactions as Determinants of Nanostructural Preservation in Ibuprofen-Loaded Nanoemulsions and Nanoemulsion Gels. Pharmaceutics 17, 1532. https:\/\/doi.org\/10.3390\/pharmaceutics17121532 (2025).","journal-title":"Pharmaceutics"},{"key":"57435_CR59","doi-asserted-by":"publisher","unstructured":"Zheng, Y. et al. Effects of Carbopol\u00ae 934 proportion on nanoemulsion gel for topical and transdermal drug delivery: A skin permeation study. Int. J. Nanomed. 5971\u20135987. https:\/\/doi.org\/10.2147\/IJN.S119286 (2016).","DOI":"10.2147\/IJN.S119286"},{"key":"57435_CR60","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ejpb.2008.10.003","volume":"72","author":"R Cassano","year":"2009","unstructured":"Cassano, R., Trombino, S., Muzzalupo, R., Tavano, L. & Picci, N. A novel dextran hydrogel linking trans-ferulic acid for the stabilization and transdermal delivery of vitamin E. Eur. J. Pharm. Biopharm. 72, 232\u2013238. https:\/\/doi.org\/10.1016\/j.ejpb.2008.10.003 (2009).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"57435_CR61","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/14740338.2020.1728253","volume":"19","author":"R Di Caprio","year":"2020","unstructured":"Di Caprio, R. et al. Safety concerns with current treatments for psoriasis in the elderly. Exp. Opin. Drug Saf. 19, 523\u2013531 (2020).","journal-title":"Exp. Opin. Drug Saf."},{"key":"57435_CR62","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1007\/s11033-021-06445-3","volume":"48","author":"A Smajlovi\u0107","year":"2021","unstructured":"Smajlovi\u0107, A. et al. Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments. Mol. Biol. Rep. 48, 4295\u20134303 (2021).","journal-title":"Mol. Biol. Rep."},{"key":"57435_CR63","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/1346-8138.15913","volume":"48","author":"K Yamanaka","year":"2021","unstructured":"Yamanaka, K., Yamamoto, O. & Honda, T. Pathophysiology of psoriasis: A review. J. Dermatol. 48, 722\u2013731 (2021).","journal-title":"J. Dermatol."},{"key":"57435_CR64","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/1346-8138.14112","volume":"45","author":"K Nakajima","year":"2018","unstructured":"Nakajima, K. & Sano, S. Mouse models of psoriasis and their relevance. J. Dermatol. 45, 252\u2013263 (2018).","journal-title":"J. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57435-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57435-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57435-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:10:14Z","timestamp":1787573414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57435-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57435"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57435-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments were carried out in compliance with LCWU Ethics Institutional Review Board, referencing TDR\/PRD\/ETHICS\/2000.1 \u201cOperational Guidelines for Ethics Committee that Review Biomedical Research\u201d by WHO Geneva 2000, page 5 (4.5.2), WHO rules and recommendations for biologics and ARRIVE 2.0. The study received ethical approval under the reference number ORIC\/LCWU\/360.","order":2,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26450"}}